Sequential treatment with targeted and immune checkpoint inhibitor therapies in patients with BRAF positive metastatic melanoma: Real-world data.

被引：0
|
作者：
Cybulska-Stopa, Bozena
Czarnecka, Anna Malgorzata
Ostaszewski, Krzysztof
Piejko, Karolina
Zietek, Marcin
Dziura, Robert
Rutkowska, Ewa
Galus, Lukasz
Ziolkowska, Barbara
Kempa-Kaminska, Natasza
Seredynska, Joanna
Kamycka, Agnieszka
Bal, Wieslaw
Surus-Hyla, Anna
Switaj, Tomasz
Rogala, Pawel
Kaminska-Winciorek, Grazyna
Suwinski, Rafal
Mackiewicz, Jacek
Rutkowski, Piotr
机构：
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Clin Oncol, Cracow Branch, Krakow, Poland
[2] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
[3] Wroclaw Med Univ, Dept Oncol, Wroclaw, Poland
[4] Wroclaw Comprehens Canc Ctr, Dept Surg Oncol, Wroclaw, Poland
[5] Holy Cross Canc Ctr, Dept Clin Oncol, Kielce, Poland
[6] Univ Med Sci, Dept Med & Expt Oncol, Heliodor Swiecicki Clin Hosp, Poznan, Poland
[7] Maria Sklodowska Curie Natl Res Inst Oncol, Clin Radiotherapy & Chemotherapy 2, Gliwice Branch, Gliwice, Poland
[8] Wroclaw Comprehens Canc Ctr, Dept Clin Oncol, Wroclaw, Poland
[9] Podkarpacki Centrum Onkol Rzeszowie, Rzeszow, Poland
[10] Gliwice Oncol Inst, Gliwice, Poland
[11] Minist Interior & Adm Hosp, Clin Dept Oncol & Immuno Oncol, Warmian Masurian Canc Ctr, Olsztyn, Poland
[12] Maria Sklodowska Curie Natl Res Inst Oncol, Gliwice Branch, Dept Bone Marrow Transplantat & Onco Hematol, Skin Canc & Melanoma Team, Gliwice, Poland
[13] Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, Poznan, Poland
[14] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21539
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Immune checkpoint inhibitor treatment of advanced age metastatic melanoma (MM) patients.
    Hegde, Upendra P.
    Kerr, Phil
    Masternak, Sophie
    Brenner, Bruce Mark
    Grant-Kels, Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients
    Yan, Chi
    Chen, Sheau-Chiann
    Ayers, Gregory D.
    Nebhan, Caroline A.
    Roland, Joseph T.
    Weiss, Vivian L.
    Johnson, Douglas B.
    Richmond, Ann
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [43] Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysis
    Pasquali, Sandro
    Chiarion-Sileni, Vanna
    Rossi, Carlo Riccardo
    Mocellin, Simone
    CANCER TREATMENT REVIEWS, 2017, 54 : 34 - 42
  • [44] Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Teresa Kim
    Rodabe N.Amaria
    Christine Spencer
    Alexandre Reuben
    Zachary A.Cooper
    Jennifer A.Wargo
    Cancer Biology & Medicine, 2014, (04) : 237 - 246
  • [45] Real-world evidence of the impact of prior autoimmune disease on immune checkpoint inhibitor outcomes in patients with metastatic urothelial cancer
    Hoffman-Censits, J.
    Abou Alaiwi, S.
    Meyer, C. S.
    Linsenmeier, J.
    Metcalf, M.
    Satram, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S598 - S599
  • [46] Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma
    Cooper, Zachary A.
    Reuben, Alexandre
    Amaria, Rodabe N.
    Wargo, Jennifer A.
    ONCOIMMUNOLOGY, 2014, 3 (09)
  • [47] Real world treatment patterns of first-line combination therapies among patients with metastatic melanoma and BRAF mutation.
    Qiu, Ying
    Li, Zhiyi
    Tang, Jackson
    Atanasov, Pavel
    Mahmood, Syed
    Grzegorzewski, Kris
    Chen, Lei
    Chen, Joyce S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Real-world treatment patterns and clinical outcomes among subgroups of BRAF-positive metastatic melanoma patients treated with dabrafenib plus trametinib.
    Eroglu, Zeynep
    Tang, Jackson
    Byrne, Clare
    Connolly, Lucy
    Shah, Rohan
    Thach-Giao Truong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Real-world evaluation of the association between baseline metastatic patterns and clinical outcomes among patients with BRAF-positive metastatic melanoma.
    Eroglu, Zeynep
    Chandra, Sunandana
    Buchbinder, Elizabeth Iannotti
    Ling, You-Li
    Tang, Jackson
    Shah, Rohan
    Truong, Thach-Giao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] EFFECTIVENESS AND SAFETY OF BRAF INHIBITORS IN THE TREATMENT OF BRAF-MUTATED UNRESECTABLE OR METASTATIC MELANOMA: REAL WORLD DATA
    Garcia-Avello, A.
    Vega-Coca, M. D.
    Abdel-Kader-Martin, L.
    Poyatos-Ruiz, L.
    Flores-Moreno, S.
    VALUE IN HEALTH, 2016, 19 (07) : A710 - A711
12345